-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Anti-hepatitis C virus therapy in liver transplanted patients
(2367) Views (420) Full article downloads
Authors: Antonino Picciotto
Published Date January 2006
Volume 2006:2(1) Pages 39 - 44
DOI: http://dx.doi.org/10.2147/TCRM.S
Antonino Picciotto
Department of Internal Medicine, University of Genoa, Genoa, Italy
Abstract: Hepatitis C virus (HCV) management in the transplant setting is still an open issue. The therapeutic strategies being addressed include: (a) pre-transplant prophylaxis (to prevent the infection of the transplanted organ); (b) post-transplant prophylaxis (to reduce the possibility of developing acute hepatitis); (c) management once the chronic disease has already set in and stabilized. Combination therapy with peginterferon alfa-2b plus ribavirin seems to play an important role for patients with established recurrent hepatitis C.
Keywords: liver transplantation, hepatitis C, peginterferon, ribavirin
Readers of this article also read:
Update on the treatment of disseminated fusariosis: Focus on voriconazole
Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis
Clinical and molecular aspects of glucocorticoid resistant asthma
Oblimersen for the treatment of patients with chronic lymphocytic leukemia
Montelukast: its role in the treatment of childhood asthma
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
